Le Lézard
Classified in: Environment, Health, Science and technology
Subjects: PDT, ENI

Agragene's Knock-Outtm product utilizes live sterile male insects as a form of insect pest control


SAN DIEGO, Sept. 24, 2019 /PRNewswire/ -- Agragene Inc. today announced that it has acquired an exclusive, worldwide license to Precision-Guided Sterile Insect TechnologyTM from the University of California. Agragene uses this technology to create environmentally responsible insect pest control products for growers. With insecticide resistance increasing and retail pesticide costs escalating, we offer growers better and more cost-effective alternatives to chemical pesticides.

Agragene Logo

"With Knock-OutTM, our goal is to bring effective and safe crop pest control to growers at a fraction of the cost of the chemical insecticides that they are using today," said Gordon Robert Alton, President and Chief Executive Officer, Agragene. "By deploying our sterile male insects into growers' fields with autonomous drones they now have an approach that requires essentially no field labor. Currently, the agricultural sector is facing enormous shortages of migrant labor and our solution alleviates this major expense.  By eliminating insecticides the growers' crop may be organically certified thereby further increasing profits."

The Knock-OutTM product brings cutting edge, proprietary genomic technology to a decades old technology known as sterile insect technique. Agragene's approach provides safe precise control and an exceptionally cost-effective solution to deploying sterile male insects onto growers' fields.

"We have created an eco-friendly product that is safe for bees, safe for birds and protects workers. Consumers will enjoy healthy pesticide-free organic food," said David Webb, Chairman of the Board, Agragene. "This is a smart, ecologically sustainable and profitable business for all of us."

Knock-OutTM benefits include:

About Agragene
Agragene is a biotechnology company founded in 2017 based in San Diego, CA. Agragene is the smart choice for organic crop pest control. Using advanced CRISPR-based genome engineering Agragene creates insect birth control products that are applicable to thousands of insect pests worldwide. Agragene's initial Knock-OutTM product targets spotted wing drosophila, a major global crop pest. The company is developing its technology for near-term commercial launch in the United States and establishing partnerships for future commercialization in other countries worldwide.  

Learn more at agragene.com and follow us on LinkedIn https://www.linkedin.com/company/agragene-inc

 

SOURCE Agragene


These press releases may also interest you

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...

at 07:05
Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first...

at 07:05
Mind Medicine (MindMed) Inc. , (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study...

at 07:05
Mission Bio, a leader in single-cell multiomic solutions for precision medicine, today announced the launch of a new single-cell capability that enhances our understanding of translocations (chromosomal rearrangements) in gene-edited therapies....

at 07:05
Aldeyra Therapeutics, Inc. (Aldeyra) will host the Aldeyra 2024 Research & Development Day with investors and financial analysts in New York City to present recent pipeline developments relating to the RASP modulation platform and ADX-2191 for the...



News published on and distributed by: